Clinical Trials Browser

Phase 2 × Carcinoma, Renal Cell × Surveys and Questionnaires × Clear all

NCT01392183 2021-09-20

Pazopanib Versus Temsirolimus in Poor-Risk Clear-Cell Renal Cell Carcinoma (RCC)

Phase 2 Completed

69 enrolled 15 charts

Pathologic Complete Response, Carcinoma, Renal Cell, Kidney Neoplasms, Neoplasm Metastasis

NCT02060370 2020-02-27

Sunitinib Scheduling in Metastatic Renal Cell Carcinoma (mRCC)

Phase 2 Completed

60 enrolled 13 charts

Carcinoma, Renal Cell, Kidney Neoplasms, Urogenital Neoplasms